Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CRYptogenic STroke And underLying AF Trial

NCT00924638 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.

NCT NCT00924638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00924638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CRYptogenic STroke And underLying AF Trial
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2009
Completion date
May 31, 2013
Enrollment
447 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

cryptogenic ischemic stroke, cryptogenic symptomatic transient ischemic attack